Literature DB >> 14506057

Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin.

Inga Odenholt1, Elisabeth Löwdin, Otto Cars.   

Abstract

Postantibiotic effects (PAEs), postantibiotic sub-MIC effects, and sub-MIC effects of the new nonfluoroquinolone PGE-9509924, ciprofloxacin, and levofloxacin against gram-positive and gram-negative strains were investigated. In comparison to ciprofloxacin and levofloxacin, PGE-9509924 exerted very similar PAEs against all strains except for both strains of Streptococcus pneumoniae, where longer PAEs were found for PGE-9509924. All three investigated quinolones showed no minimal PAEs against Pseudomonas aeruginosa.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14506057      PMCID： PMC201171          DOI： 10.1128/AAC.47.10.3352-3356.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  Postantibiotic effects of grepafloxacin compared to those of five other agents against 12 gram-positive and -negative bacteria.

Authors:  S K Spangler; S Bajaksouzian; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

Review 2.  Does the dose matter?

Authors:  W A Craig
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

3.  Effects of supra- and sub-MIC benzylpenicillin concentrations on group A beta-haemolytic streptococci during the postantibiotic phase in vivo.

Authors:  I Odenholt; S E Holm; O Cars
Journal:  J Antimicrob Chemother       Date:  1990-08       Impact factor: 5.790

Review 4.  The post-antibiotic sub-MIC effect in vitro and in vivo.

Authors:  O Cars; I Odenholt-Tornqvist
Journal:  J Antimicrob Chemother       Date:  1993-05       Impact factor: 5.790

Review 5.  Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

Authors:  W A Craig
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

6.  Pharmacodynamic studies of trovafloxacin and grepafloxacin in vitro against Gram-positive and Gram-negative bacteria.

Authors:  I Odenholt; T Cars; E Lowdin
Journal:  J Antimicrob Chemother       Date:  2000-07       Impact factor: 5.790

7.  In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV.

Authors:  Mark E Jones; Ian A Critchley; James A Karlowsky; Renée S Blosser-Middleton; Franz-Josef Schmitz; Clyde Thornsberry; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

8.  Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

9.  Postantibiotic effect, and postantibiotic effect of subinhibitory concentrations, of sparfloxacin on gram-negative bacteria.

Authors:  I Odenholt-Tornqvist; S Bengtsson
Journal:  Chemotherapy       Date:  1994 Jan-Feb       Impact factor: 2.544

10.  Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro.

Authors:  I Odenholt-Tornqvist; E Löwdin; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191
View more
  5 in total

1.  Antibacterial activities of nemonoxacin against clinical isolates of Staphylococcus aureus: an in vitro comparison with three fluoroquinolones.

Authors:  Zhaoxia Li; Youning Liu; Rui Wang; Aimin Li
Journal:  World J Microbiol Biotechnol       Date:  2014-08-18       Impact factor: 3.312

2.  In vitro activity and post-antibiotic effects of linezolid in combination with fosfomycin against clinical isolates of Staphylococcus aureus.

Authors:  Hao Chen; Lan Li; Yanyan Liu; Maomao Wu; Shuangli Xu; Guijun Zhang; Caifen Qi; Yan Du; Mingli Wang; Jiabin Li; Xiaohui Huang
Journal:  Infect Drug Resist       Date:  2018-11-01       Impact factor: 4.003

3.  In vitro and in vivo Antibacterial Activity of Linezolid Plus Fosfomycin Against Staphylococcus aureus with Resistance to One Drug.

Authors:  Na Xie; Lifang Jiang; Mingtao Chen; Guijun Zhang; Yanyan Liu; Jiabin Li; Xiaohui Huang
Journal:  Infect Drug Resist       Date:  2021-02-24       Impact factor: 4.003

4.  Benzohydrazide and Phenylacetamide Scaffolds: New Putative ParE Inhibitors.

Authors:  Vidyasrilekha Yele; Bharat Kumar Reddy Sanapalli; Ashish D Wadhwani; Afzal Azam Mohammed
Journal:  Front Bioeng Biotechnol       Date:  2021-06-17

5.  A synthetic peptide sensitizes multi-drug resistant Pseudomonas aeruginosa to antibiotics for more than two hours and permeabilizes its envelope for twenty hours.

Authors:  Iosu Rázquin-Olazarán; Hawraa Shahrour; Guillermo Martínez-de-Tejada
Journal:  J Biomed Sci       Date:  2020-08-06       Impact factor: 8.410
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.